Biokine Therapeutics' Other Investors

Biokine Therapeutics raised a round of funding on , . Investors include Clal Biotechnology Industries.

Biokine Therapeutics is focused on developing novel anti-cancer and stem cells mobilization drugs to treat cancer patients. Biokine targets CXCR4 chemokine receptor, which is critical to the developme…

Articles about Biokine Therapeutics' Other Investors: